Skip to main content

Table 2 Pathological findings

From: Impact of the new guidelines of the American Thyroid Association on the treatment of the differentiated thyroid tumor in an Italian center with medium-high volume thyroid surgery

All patients (2014–2016)

197

Total thyroidectomy

194

Lobohystmectomy

3

Neoplastic disease

46/197 (23.3%)

- Preoperative malignant cytology

28/46 (60.9%)

- Incidental malignant disease

18/46 (39.1%)

Hystotype

- Papillary carcinoma

42/46 (91.4%)

- Follicular carcinoma

2/46 (4.3%)

- Hurtle cells carcinoma

2/46 (4.3%)

Multifocal neoplastic disease

4/46 (8.7%)

Benign disease

151 (76.7%)